Equillium, Inc. (EQ)
2.20
-0.11
(-4.76%)
USD |
NASDAQ |
Aug 24, 16:00
2.24
+0.04
(+1.82%)
After-Hours: 20:00
Equillium Total Liabilities (Quarterly) : 2.65M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.65M |
| March 31, 2026 | 3.596M |
| December 31, 2025 | 3.453M |
| September 30, 2025 | 3.567M |
| June 30, 2025 | 7.343M |
| March 31, 2025 | 6.151M |
| December 31, 2024 | 6.667M |
| September 30, 2024 | 11.28M |
| June 30, 2024 | 20.43M |
| March 31, 2024 | 22.50M |
| December 31, 2023 | 27.96M |
| September 30, 2023 | 31.12M |
| June 30, 2023 | 31.78M |
| March 31, 2023 | 42.52M |
| December 31, 2022 | 46.48M |
| September 30, 2022 | 20.47M |
| Date | Value |
|---|---|
| June 30, 2022 | 22.20M |
| March 31, 2022 | 21.60M |
| December 31, 2021 | 18.90M |
| September 30, 2021 | 16.67M |
| June 30, 2021 | 15.06M |
| March 31, 2021 | 14.96M |
| December 31, 2020 | 15.57M |
| September 30, 2020 | 14.26M |
| June 30, 2020 | 13.29M |
| March 31, 2020 | 13.56M |
| December 31, 2019 | 13.69M |
| September 30, 2019 | 14.04M |
| June 30, 2019 | 3.825M |
| March 31, 2019 | 3.233M |
| December 31, 2018 | 2.228M |
| September 30, 2018 | 16.80M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 446.97M |
| Fortress Biotech, Inc. | 110.63M |
| Cue Biopharma, Inc. | 28.40M |
| Legend Biotech Corp. | 521.32M |
| Dianthus Therapeutics, Inc. | 41.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.67M |
| Shareholders Equity (Quarterly) | 56.02M |
| Debt to Equity Ratio | 0.0104 |
| Current Ratio | 23.40 |
| Net Debt Paydown Yield | -0.03% |